ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,274.03
-0.22%
Dow Jones
40,539.93
-0.12%
Gold vs US Dollar
2,390.175
0.37%
Brent Oil
78.95
-0.25%
Bitcoin
66,629.64
-0.29%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
30/07/202411:45UK RegulatoryShare repurchase programmeLSE:0NQJRtx A/s
30/07/202411:45UK RegulatoryBioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patients with Advanced MelanomaTG:22UABioNTech SE
30/07/202411:45UK RegulatoryBioNTech gibt erste positive Ergebnisse aus laufender Phase-2-Studie mit mRNA-basiertem Immuntherapiekandidaten BNT111 bei fortgeschrittenem Hautkrebs bekanntTG:22UABioNTech SE
30/07/202411:45UK RegulatoryBioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patients with Advanced MelanomaXE:22UABioNTech SE
30/07/202411:45UK RegulatoryBioNTech gibt erste positive Ergebnisse aus laufender Phase-2-Studie mit mRNA-basiertem Immuntherapiekandidaten BNT111 bei fortgeschrittenem Hautkrebs bekanntLSE:0A3MBiontech Se
30/07/202411:45UK RegulatoryBioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patients with Advanced MelanomaLSE:0A3MBiontech Se
30/07/202411:45UK RegulatoryBioNTech gibt erste positive Ergebnisse aus laufender Phase-2-Studie mit mRNA-basiertem Immuntherapiekandidaten BNT111 bei fortgeschrittenem Hautkrebs bekanntXE:22UABioNTech SE
30/07/202411:44UK RegulatoryStrategic Equity Capital Plc - Net Asset Value(s)LSE:SECStrategic Equity Capital Plc
30/07/202411:43PR Newswire (US)DIFC continues to drive the future of finance with outstanding H1 2024 results
30/07/202411:42PR Newswire (US)Global Telecom Tower Power System Market Size to Progress at a CAGR of 6.7% through 2034 Amid Increasing Demand for Uninterrupted Connectivity | Future Market Insights, Inc.
30/07/202411:41UK RegulatoryMiton UK Microcap Trust Plc - Net Asset Value(s)LSE:MINIMiton Uk Microcap Trust Plc
30/07/202411:36Alliance NewsAlliance NewsSomero reduces 2024 revenue expectations due to "inclement" weatherLSE:SOMSomero Enterprise Inc.
30/07/202411:36UK RegulatoryInvesco Global Equity Income Trust Plc - Net Asset Value(s)LSE:IGETInvesco Global Equity Income Trust Plc
30/07/202411:35UK RegulatoryInvesco Asia Trust Plc - Net Asset Value(s)LSE:IATInvesco Asia Trust Plc
30/07/202411:32PR Newswire (US)Akamai Research: Web Attacks Targeting Applications and APIs Up by 49% in the Last YearNASDAQ:AKAMAkamai Technologies Inc
30/07/202411:32UK RegulatoryBCI Agrees to Sell Majority Stake in Hayfin
30/07/202411:32UK RegulatoryInvesco Perpetual UK Smaller Co's Investment Trust Plc - Net Asset Value(s)LSE:IPUInvesco Perpetual Uk Smaller Companies Investment Trust Plc
30/07/202411:32UK RegulatoryInvesco Bond Income Plus Ltd - Net Asset Value(s)LSE:BIPSInvesco Bond Income Plus Limited
30/07/202411:31Alliance NewsAlliance NewsUK finance watchdog extends probe into car finance mis-selling
30/07/202411:30UK RegulatoryMiddleGround Capital übernimmt Mehrheitsbeteiligung an Helix
30/07/202411:30UK RegulatoryMiddleGround Capital Completes Acquisition of Majority Ownership Stake in Helix
30/07/202411:30UK RegulatoryMiddleGround Capital officialise l’acquisition d’une participation majoritaire dans elix Intergral Powertrain
30/07/202411:30PR Newswire (US)2024-2025 NEXT for AUTISM FELLOWS RECIPIENTS ARE ANNOUNCED
30/07/202411:30PR Newswire (US)HYSTER-YALE ANNOUNCES DATES OF SECOND QUARTER 2024 EARNINGS RELEASE AND WEBCASTNYSE:HYHyster Yale Inc
30/07/202411:30PR Newswire (US)Graphic Packaging Holding Company Reports Second Quarter 2024 Financial ResultsNYSE:GPKGraphic Packaging Holding Company
30/07/202411:30PR Newswire (US)White Castle Fights Inflation by Rolling Back the Clock and the Prices for a Sack of 10 Cheese Sliders
30/07/202411:30PR Newswire (US)European Medicines Agency (EMA) Approves Bio-Thera Solutions' BAT1706 (Avzivi®, bevacizumab), a biosimilar referencing Avastin®
30/07/202411:30PR Newswire (US)Premier LogiTech Announces Global Motorola Brand License Rights for Networking Products
30/07/202411:30UK RegulatoryInvesco Investment Trusts - Net Asset Value(s)
30/07/202411:26Alliance NewsAlliance NewsInchcape increases buyback programme as first-half profit jumps 10%LSE:INCHInchcape Plc

Your Recent History

LSE
UKOG
Uk Oil & Gas
LSE
SCLP
Scancell
LSE
LLOY
Lloyds Banking
LSE
GDR
Genedrive
LSE
SOLG
Solgold
LSE
VAST
Vast Resources
LSE
GWMO
Great Western Mining
LSE
SYME
Supply@me Capital
LSE
DGE
Diageo
LSE
SBTX
Skinbiotherapeutics
LSE
SQZ
Serica Energy
LSE
POS
Plexus
LSE
OCDO
Ocado
LSE
AAZ
Anglo Asian Mining
LSE
GKP
Gulf Keystone Petroleum
LSE
QBT
Quantum Blockchain Techn...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved